About Daniel Haders
Daniel Haders is president of Model Medicines, which designs potential medicines for human diseases. A U.S. patent on treatments for viral infections names Haders and is assigned to Model Medicines.
Experience
This experience comes from Daniel Haders's profile and from SEC filings. For roles taken from filings, the years are when the filings name Daniel Haders in the role, so the role may have started earlier or lasted longer.
Model Medicines, Inc. Current
Founder, CEO
President
2021 – Present · San Diego, CA
Model Medicines uses AI to design drug compounds aimed at disease-driving biology.
CV
Columbia Technology Ventures Current
BioMedX Oversight Committee
2020 – Present
TH
Together.Health Current
Steering Committee Member
2020 – Present
UF
University of California, San Francisco Current
Advisor, Catalyst Program
2018 – Present
Consano Bio, Inc.
Member Board of Directors
2023 – 2025 · Burlington, MA
Develops an investigational non-opioid treatment for people with chronic sciatica.
RP
Regenexx Corporate Program
Board Member
2022 – 2024
AP
AppliedVR
Board Member (Observer)
2020 – 2023
SV
Sway Ventures
Operating Partner
2018 – 2023
UD
University of California San Diego
Faculty and Member of Advisory Committee - Digital Health Certificate
2019 – 2022
NC
Nex Cubed
Managing Director, Digital Health
2017 – 2021
ME
MedCrypt
Advisor
2018 – 2019
CC
Columbia Venture Community
Co-Founder San Diego CVC
2018
CY
Columbia University in the City of New York
Member Board Of Directors - Columbia Alumni Association of San Diego
2017 – 2018
QU
QuiO
Senior Strategic Advisor
2016 – 2018
SB
Sanar Biosciences
Founder, President & CEO
2010 – 2016
LI
Lux Biosciences, Inc.
Senior Scientist
2007 – 2009
NT
New Jersey Commission on Science and Technology
Postdoctoral Fellow
2007 – 2009
RU
Rutgers University
Robert G. Ackerman Fellow
2006 – 2008
UE
U.S. Department of Education
GAANN Fellow in Molecular, Cellular and Nanosystems Bioengineering
2006 – 2007
NF
National Science Foundation
IGERT Fellow in Integratively Engineered Biointerfaces
2004 – 2006
Key Colleagues at Startups
The people Daniel Haders works with at each company, as listed on that company's latest Form D.
Consano Bio, Inc. · Form D, Jun 13, 2023
WS
Wayne Schellhammer
Interim CEO and director
CH
Clayton Hartman
Director
RL
REGENEXX HOLDINGS, LLC
Sole Member